Theraglass Limited in London, E1 6DY

Description

Data updated on: 01-11-2023

This particular company is located in London under the ID 06813496. The firm was established in the year 2009. The office of the firm is located at 4th Floor 36 Spital Square. The postal code for this location is E1 6DY. The enterprise's Standard Industrial Classification Code is 72110 and their NACE code stands for Research and experimental development on biotechnology. Tue, 28th Feb 2023 is the last time when company accounts were filed.

According to the official data, the limited company is controlled by a solitary managing director: Paul C., who was appointed on 2009-02-09. The limited company had been directed by Kenneth M. until 2009. In order to provide support to the directors, the abovementioned limited company has been utilizing the expertise of Graham M. as a secretary since 2009.

Paul C. is the individual who has control over this firm, owns over 3/4 of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-02-28	2012-02-28	2013-02-28	2014-02-28	2015-02-28	2016-02-28	2017-02-28	2018-02-28	2019-02-28	2020-02-29	2021-02-28	2022-02-28	2023-02-28
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	1 098 163	3 139 528	2 819 963	2 556 467	2 311 013	2 043 073	1 778 584

Balance Sheet
Current Assets	2 710	2 475	2 053	3 557	11 177	2 644	10 656	4 059	2 630	2 430	2 430	2 430	2 310
Net Assets Liabilities							1 778 584	1 512 986	1 252 544	993 331	734 318	475 305	391 225
Cash Bank In Hand	2 336	255	2 052	3 556
Debtors	373	2 219
Intangible Fixed Assets	3 599 999	3 149 999	2 834 999	2 575 999
Net Assets Liabilities Including Pension Asset Liability	1 098 163	3 139 528	2 819 963	2 556 467	2 311 013	2 043 073	1 778 584
Stocks Inventory	1	1	1	1

Capital & Reserves
Called Up Share Capital	909	2 500 909	2 500 909	2 500 909
Profit Loss Account Reserve	-927 467	-1 386 102	-1 705 667	-1 969 163
Shareholder Funds	1 098 163	3 139 528	2 819 963	2 556 467	2 311 013	2 043 073	1 778 584

Other Financial Data
Average Number Employees During Period										1	1	1	1
Creditors							31 071	31 072	31 085	31 098	31 111	31 124	31 084
Fixed Assets	3 599 999	3 149 999	2 834 999	2 575 999	2 316 999	2 057 999	1 798 999	1 539 999	1 280 999	1 021 999	762 999	503 999	419 999
Net Current Assets Liabilities	-1 836	-10 471	-15 036	-19 532	-5 986	-14 926	-20 415	27 013	-28 455	-28 668	-28 681	-28 694	-28 774
Total Assets Less Current Liabilities	3 598 163	3 139 528	2 819 963	2 556 467	2 311 013	2 043 073	1 778 584	1 512 986	1 252 544	993 331	734 318	475 305	391 225
Creditors Due After One Year Total Noncurrent Liabilities	2 500 000	2 500 000
Creditors Due Within One Year Total Current Liabilities	4 546	12 946
Intangible Fixed Assets Aggregate Amortisation Impairment	900 000	1 350 000	1 665 000	1 924 000
Intangible Fixed Assets Amortisation Charged In Period		450 000	315 000	259 000
Intangible Fixed Assets Cost Or Valuation	4 499 999	4 499 999	4 499 999	4 499 999
Share Premium Account	2 024 721	2 024 721	2 024 721	2 024 721
Creditors Due Within One Year		12 946	17 089	23 089	17 163	17 570	31 071
Number Shares Allotted			2 500 000	2 500 000
Par Value Share			1	1
Share Capital Allotted Called Up Paid		2 500 000	2 500 000	2 500 000
Amount Specific Advance Or Credit Directors			16 084	22 084

Company staff

Paul C.

Role: Director

Appointed: 09 February 2009

Latest update: 23 April 2024

Graham M.

Role: Secretary

Appointed: 09 February 2009

Latest update: 23 April 2024

People with significant control

Paul C.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

Michael H.

Notified on 6 April 2016

Ceased on 5 January 2022

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	30 November 2024
Account last made up date	28 February 2023
Confirmation statement next due date	23 February 2024
Confirmation statement last made up date	09 February 2023

Annual Accounts 28 November 2013
Start Date For Period Covered By Report	2012-02-29
End Date For Period Covered By Report	2013-02-28
Date Approval Accounts	28 November 2013
Annual Accounts 29 November 2014
Start Date For Period Covered By Report	2013-03-01
End Date For Period Covered By Report	2014-02-28
Date Approval Accounts	29 November 2014
Annual Accounts 30 November 2015
Start Date For Period Covered By Report	2014-03-01
End Date For Period Covered By Report	2015-02-28
Date Approval Accounts	30 November 2015
Annual Accounts 26 November 2016
Start Date For Period Covered By Report	2015-03-01
End Date For Period Covered By Report	2016-02-28
Date Approval Accounts	26 November 2016
Annual Accounts 28 November 2017
Start Date For Period Covered By Report	2016-02-29
End Date For Period Covered By Report	2017-02-28
Date Approval Accounts	28 November 2017
Annual Accounts
Start Date For Period Covered By Report	2017-03-01
End Date For Period Covered By Report	2018-02-28
Annual Accounts
Start Date For Period Covered By Report	01 March 2018
End Date For Period Covered By Report	28 February 2019
Annual Accounts
Start Date For Period Covered By Report	01 March 2019
End Date For Period Covered By Report	29 February 2020
Annual Accounts
Start Date For Period Covered By Report	01 March 2020
End Date For Period Covered By Report	28 February 2021
Annual Accounts
Start Date For Period Covered By Report	01 March 2021
End Date For Period Covered By Report	28 February 2022
Annual Accounts
Start Date For Period Covered By Report	01 March 2022
End Date For Period Covered By Report	28 February 2023

Theraglass Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Paul C.

Graham M.

Kenneth M.

People with significant control

Paul C.

Michael H.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies